{"disease":{"id":"hsil-high-grade-squamous-intraepithelial-lesions","name":"hsil high grade squamous intraepithelial lesions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05282745","title":"A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT04190472","title":"Intraoperative HPV Testing Evaluation","phase":"","overall_status":"UNKNOWN","enrollment_count":1553,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT05283239","title":"Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05745597","title":"Prognostic Study of HPV Virus Integration in Women With HSIL","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05282095","title":"Effect of HPV Integration on Prognosis of Young Women With CIN2 in China","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05060640","title":"ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University Fernando Pessoa","has_results":false},{"nct_id":"NCT06356012","title":"Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Barretos Cancer Hospital","has_results":false},{"nct_id":"NCT03202992","title":"Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT03239223","title":"Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT03697226","title":"Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT03677960","title":"Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Antiva Biosciences","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}